Drug Development

Listings
  • Anti-IL13RA2 (clone hu08)-Mc- ADC

    Anti-IL13RA2 (clone hu08)-Mc- ADC

    Drug Development Shirley (New York) December 18, 2017 1.00 Dollar US$

    https://www.creative-biolabs.com/adc/target-il13ra2-57.htm This ADC product is comprised of an anti- IL13RA2 monoclonal antibody (clone hu08) conjugated via a Mc linker to a drug. Noncleavable linkers, is considered noncleavable-meaning linker cleava...

  • Anti-IL13RA2 (clone hu08)-Mc- ADC

    Anti-IL13RA2 (clone hu08)-Mc- ADC

    Drug Development Shirley (New York) December 18, 2017 1.00 Dollar US$

    https://www.creative-biolabs.com/adc/target-il13ra2-57.htm This ADC product is comprised of an anti- IL13RA2 monoclonal antibody (clone hu08) conjugated via a Mc linker to a drug. Noncleavable linkers, is considered noncleavable-meaning linker cleava...

  • Anti-IL13RA2 (clone hu08)-MalPeg ADC

    Anti-IL13RA2 (clone hu08)-MalPeg ADC

    Drug Development Shirley (New York) December 18, 2017 1.00 Dollar US$

    https://www.creative-biolabs.com/adc/target-il13ra2-57.htm This ADC product is comprised of an anti- IL13RA2 monoclonal antibody (clone hu08) conjugated via an MalPeg linker to a drug. Noncleavable linkers, is considered noncleavable-meaning linker c...

  • Anti-HAVCR1 (clone CR-014)-VC-MMAE ADC

    Anti-HAVCR1 (clone CR-014)-VC-MMAE ADC

    Drug Development Shirley (New York) December 18, 2017 1.00 Dollar US$

    https://www.creative-biolabs.com/adc/target-havcr1-53.htm This ADC product is comprised of an anti-HAVCR1 monoclonal antibody (clone CR-014) conjugated via a VC linker to MMAE. The MMAE is targeted to certain cancers by immunerecognition and delivere...

  • Anti-GUCY2C (clone 5F9)-VC-MMAE ADC

    Anti-GUCY2C (clone 5F9)-VC-MMAE ADC

    Drug Development Shirley (New York) December 18, 2017 1.00 Dollar US$

    https://www.creative-biolabs.com/adc/target-gucy2c-52.htm This ADC product is comprised of an anti-GUCY2C monoclonal antibody (clone 5F9) conjugated via a VC linker to MMAE. The MMAE is targeted to certain cancers by immunerecognition and delivered i...

  • Anti-GUCY2C (clone 5F9)-MMAE ADC

    Anti-GUCY2C (clone 5F9)-MMAE ADC

    Drug Development Shirley (New York) December 18, 2017 1.00 Dollar US$

    https://www.creative-biolabs.com/adc/target-gucy2c-52.htm This ADC product is comprised of an anti-GUCY2C monoclonal antibody (clone 5F9)conjugated via a Cleavable peptide linker to a MMAE. The MMAE is targeted to certain cancers by immunerecognition...

  • Anti-GUCY2C (clone 5F9)-Mc-MMAF ADC

    Anti-GUCY2C (clone 5F9)-Mc-MMAF ADC

    Drug Development Shirley (New York) December 18, 2017 1.00 Dollar US$

    https://www.creative-biolabs.com/adc/target-gucy2c-52.htm This ADC product is comprised of an anti-GUCY2C monoclonal antibody (clone 5F9) conjugated via a Mc linker to MMAF. The MMAF is targeted to certain cancers by immunerecognition and delivered i...

  • Anti-GUCY2C (clone 5F9)-VC-MMAE ADC

    Anti-GUCY2C (clone 5F9)-VC-MMAE ADC

    Drug Development Shirley (New York) December 18, 2017 1.00 Dollar US$

    https://www.creative-biolabs.com/adc/target-gucy2c-52.htm This ADC product is comprised of an anti-GUCY2C monoclonal antibody (clone 5F9) conjugated via a VC linker to MMAE. The MMAE is targeted to certain cancers by immunerecognition and delivered i...

  • Anti-GPNMB-VC-MMAE ADC

    Anti-GPNMB-VC-MMAE ADC

    Drug Development Shirley (New York) December 18, 2017 1.00 Dollar US$

    https://www.creative-biolabs.com/adc/target-gpnmb-51.htm This ADC product is comprised of an anti-GPNMB monoclonal antibody conjugated via a VC linker to MMAF. The MMAF is targeted to certain cancers by immunerecognition and delivered into cancer cel...

  • Anti-Fyn3 (clone SC16)-D6.5 ADC

    Anti-Fyn3 (clone SC16)-D6.5 ADC

    Drug Development Shirley (New York) December 18, 2017 1.00 Dollar US$

    https://www.creative-biolabs.com/adc/target-fyn3-50.htm This ADC product is comprised of an anti-Fyn3 monoclonal antibody (clone SC16) conjugated via a linker to D6.5. Pyrrolobenzodiazepine (PBD) dimmers are highly cytotoxic DNA cross-linking agents....

  • Anti-FXYD5 (clone M53)-PEG-cardiac glycoside ADC

    Anti-FXYD5 (clone M53)-PEG-cardiac glycoside ADC

    Drug Development Shirley (New York) December 18, 2017 1.00 Dollar US$

    https://www.creative-biolabs.com/adc/target-fxyd5-49.htm This ADC product is comprised of an anti-FXYD5 monoclonal antibody (clone M53) conjugated via a PEG linker to cardiac glycoside. Noncleavable linkers, is considered noncleavable-meaning linker ...

  • Anti-FUT3 (clone BR96)-Mc-VC-PABC-MMAF ADC

    Anti-FUT3 (clone BR96)-Mc-VC-PABC-MMAF ADC

    Drug Development Shirley (New York) December 18, 2017 1.00 Dollar US$

    https://www.creative-biolabs.com/adc/target-fut3-48.htm This ADC product is comprised of an anti-FUT3 monoclonal antibody (clone BR96) conjugated via a Mc-VC-PABC linker to MMAF. The MMAF is targeted to certain cancers by immunerecognition and delive...